Costa-Verdera H, et al. Understanding and tackling immune responses to adeno-associated viral vectors. Human Gene Therapy. 2023;34(17–18):836–52.

Article  CAS  PubMed  Google Scholar 

Dai Y, et al. Comparison of pre-existing anti-AAV8 total antibody screening and confirmatory assays with a cell-based neutralizing assay in normal human serum. AAPS J. 2023;25(3):35.

Article  CAS  PubMed  Google Scholar 

Kavita U, Dai Y, Salvador L, Miller W, Adam LP, Levesque PC, Zhang YJ, Ji QC, Pillutla RC. development of a chemiluminescent elisa method for the detection of total anti-adeno associated virus serotype 9 (AAV9) antibodies. Hum Gene Ther Methods. 2018;29(6):237–50.

Haar J, et al. MSD-based assays facilitate a rapid and quantitative serostatus profiling for the presence of anti-AAV antibodies. Mol Ther Methods Clin Dev. 2022;25:360–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Falese L, et al. Strategy to detect pre-existing immunity to AAV gene therapy. Gene Ther. 2017;24(12):768–78.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pan Y, Rohde M, Zeitler J, Namburi SVS, Cao L, Hu J, Meyer K, Lu Y. A sensitive AAV transduction inhibition assay assists evaluation of critical factors for detection and concordance of pre-existing antibodies. Mol Ther Methods Clin Dev. 2023;31:101126.

Simmons E, Wen Y, Li J, Qian YW, Wong LC, Konrad RJ, Bivi N. A sensitive and drug tolerant assay for detecting anti-AAV9 antibodies using affinity capture elution. J Immunol Methods. 2023;512:113397.

Cao L, Ledeboer A, Pan Y, Lu Y, Meyer K. Clinical enrollment assay to detect preexisting neutralizing antibodies to AAV6 with demonstrated transgene expression in gene therapy trials. Gene Ther. 2023;30(1–2):150–9.

Dai Y, et al. Prevalence of pre-existing neutralizing antibodies against adeno-associated virus serotypes 1, 2, 5, 6, 8, and 9 in sera of different pig strains. Hum Gene Ther. 2022;33(7–8):451–9.

Article  CAS  PubMed  Google Scholar 

Long BR, et al. The impact of pre-existing immunity on the non-clinical pharmacodynamics of aav5-based gene therapy. Mol Ther Methods Clin Dev. 2019;13:440–52.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Butala-Flores E, Nguyen T, Selvan N, Armstrong L, Miller M, Kamen L, Lester T, Wernyj R, Khanna R, McNally J, Hays A. Validation of anti-adeno associated virus serotype rh10 (AAVrh.10) total and neutralizing antibody immunogenicity assays. Pharm Res. 2023;40(10):2383–97.

Mendell JR, et al. Testing preexisting antibodies prior to AAV gene transfer therapy: rationale, lessons and future considerations. Mol Ther Methods Clin Dev. 2022;25:74–83.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Schulz M, et al. Binding and neutralizing anti-AAV antibodies: Detection and implications for rAAV-mediated gene therapy. Mol Ther. 2023;31(3):616–30.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Oyama H, et al. Characterization of adeno-associated virus capsid proteins with two types of vp3-related components by capillary gel electrophoresis and mass spectrometry. Hum Gene Ther. 2021;32(21–22):1403–16.

CAS  PubMed  PubMed Central  Google Scholar 

Kamat V, Rafique A. Extending the throughput of Biacore 4000 biosensor to accelerate kinetic analysis of antibody-antigen interaction. Anal Biochem. 2017;530:75–86.

Article  CAS  PubMed  Google Scholar 

Jin X, et al. Direct liquid chromatography/mass spectrometry analysis for complete characterization of recombinant adeno-associated virus capsid proteins. Hum Gene Ther Methods. 2017;28(5):255–67.

Article  CAS  PubMed  Google Scholar 

Liu AP, et al. Characterization of Adeno-associated virus capsid proteins using hydrophilic interaction chromatography coupled with mass spectrometry. J Pharm Biomed Anal. 2020;189:113481.

Article  CAS  PubMed  Google Scholar 

Guapo F, et al. Fast and efficient digestion of adeno associated virus (AAV) capsid proteins for liquid chromatography mass spectrometry (LC-MS) based peptide mapping and post translational modification analysis (PTMs). J Pharm Biomed Anal. 2022;207:114427.

Article  CAS  PubMed  Google Scholar 

Serrano MAC, et al. Mass spectrometry in gene therapy: Challenges and opportunities for AAV analysis. Drug Discov Today. 2023;28(1):103442.

Article  CAS  PubMed  Google Scholar 

Ryan JP, et al. Characterizing adeno-associated virus capsids with both denaturing and intact analysis methods. J Am Soc Mass Spectrom. 2023;34(12):2811–21.

Article  CAS  PubMed  Google Scholar 

Mulcrone PL, et al. Chemical modification of AAV9 capsid with N-ethyl maleimide alters vector tissue tropism. Sci Rep. 2023;13(1):8436.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Klamroth R, et al. Global seroprevalence of pre-existing immunity against AAV5 and other AAV Serotypes in people with hemophilia A. Human Gene Ther. 2022;33(7–8):432–41.

Article  CAS  Google Scholar 

Jiang Y, et al. Simple method to determine the concentration and incorporation ratio of ruthenium-labeled antibodies. Bioanalysis. 2022;14(1):19–28.

Article  CAS  PubMed  Google Scholar 

Sommer JM, et al. Quantification of adeno-associated virus particles and empty capsids by optical density measurement. Mol Ther. 2003;7(1):122–8.

Article  CAS  PubMed  Google Scholar